Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.66 |
| ▸ | CALCRL | Q16602 | 5/20 | 0.60 |
| ▸ | REN | P00797 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.50 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.50 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31684806 | 0.98 | SLC6A2 (0.69) | SLC6A2CALCRLRENOPRM1OPRD1 | |
| SCHEMBL31233755 | 0.94 | SLC6A2 (0.64) | SLC6A2CALCRLOPRM1OPRD1NTSR2 | |
| SCHEMBL31233911 | 0.93 | SLC6A2 (0.63) | SLC6A2CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL31233798 | 0.93 | SLC6A2 (0.63) | SLC6A2CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL29465927 | 0.91 | SLC6A2 (0.62) | SLC6A2CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL29531383 | 0.89 | SLC6A2 (0.71) | SLC6A2CALCRLOPRM1OPRD1 | |
| SCHEMBL31233948 | 0.88 | SLC6A2 (0.61) | SLC6A2CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL31233933 | 0.88 | SLC6A2 (0.61) | SLC6A2CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL29530922 | 0.87 | SLC6A2 (0.64) | SLC6A2CALCRLOPRM1OPRD1NTSR2 | |
| SCHEMBL29796613 | 0.87 | NTSR1 (0.60) | SLC6A2NTSR2NTSR1SORT1AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12171734-B2 | Pathogenic bacteria | SPOREGEN LIMITED (GB) | 2024-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12171734-B2 | Pathogenic bacteria | CLPP, CLPX, ANTXR2 | SLC6A2 3807/4885CALCRL 3111/4885REN 2576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.